The contacts, manufactured by Johnson & Johnson Vision Care, contain a photochromic additive that slightly darkens the lenses in bright sunlight. The lenses return to a normal tint in normal or dark lighting conditions.
“This contact lens is the first of its kind to incorporate the same technology that is used in eyeglasses that automatically darken in the sun,” said Malvina Eydelman, MD, director of the division of ophthalmic and ear, nose and throat devices at the FDA’s Center for Devices and Radiological Health.
The contacts, available for both nearsighted and farsighted individuals, can be worn daily for up to two weeks.
More articles on supply chain:
Pharma gave patient groups $116M in 1 year: 4 findings
Why this Japanese drugmaker bought a Napa Valley winery
Novartis to acquire gene therapy firm AveXis for $8.7B
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.